Renowned Speakers

Jerzy Leszek

Wroclaw Medical University, Poland

Suresh Kumar

Cognitive Research Institute, USA

Andres Barboza

Universidad del Aconcagua Argentina

Abdullatif Azab

Eastern Plants Company, Israel

Theodore A Petti

Johns Hopkins University of Medicine, USA

Theodore A Petti

Johnson Medical School, USA

Ahmed Ammar

Dammam University, Saudi Arabia

Ad Verheul

Centre De Hartenberg Netherlands

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Stem Cell 2025, Germany Food Technology Congress 2025, Switzerland Food and Beverages 2025, UK Surgery-2025, UK

Asia Pacific & Middle East

Stress 2025, Thailand MICROBIOLOGY CONF 2025, Singapore Nursing 2025, Thailand VACCINE CONGRESS 2025, UAE

Canada

Psychosomatic Medicine 2025, Canada Virology-2025, Canada Pediatrics - 2025, Canada Big Data 2025, Canada

Dementia-2025

About Conference

With the great success of Dementia 2024, Conference Series LLC Ltd is proud to announce the “19th International Conference on Alzheimers Disease & Dementia”, which is going to be held on July 07-08, 2025 at Zurich, Switzerland.We welcome each and everyone from everypart of the world to travel to the insanity gathering that is command amid July 07-08, 2025. The principle subject of our meeting is "Advancements and Challenges in the Fields of Dementia Research" that covers intensive form of essentially important sessions. This meeting flow regarding enhancements within the field of insanity and about the new treatment techniques that square measure contrived by researchers to treat completely different maladies in less hard-to-please approach. This meeting goes concerning as a best stage for participants to search out concerning this pattern in insanity innovative work.

Dementia-2025 gathering can target the foremost recent and energizing developments in each facet of insanity think about that offers a noteworthy open door for agents over the world to fulfil, organize, and see new logical advancements. The 2 days gathering incorporates symposiums and exceptional keynote sessions semiconductor diode by notable and eminent speakers WHO exceed expectations within the field of insanity This Worldwide insanity Meeting likewise energizes the dynamic support of young understudies, forthcoming specialists and growing researchers as we have a tendency to square measure facilitating Poster Award Competition and Young analysis Forum at the gathering setting, This Dementia-2025 Conference is tailored to fulfil the needs of both eminent professionals and those just starting out in their professions. Dementia 2023 will serve as a major introduction to latest results and research in the field of Dementia and Alzheimer’s. It's a fantastic opportunity for everyone to engage in international networking and interact with world-class specialists. This worldwide Alzheimer’s summit will unite researchers, scientists, academicians, caregivers, healthcare professionals and neurology experts from all around the globe to have discussion on the latest trends and innovations in the field of dementia and Alzheimer’s. The Dementia congress strives to improve the coordination and delivery of care for those suffering from neurocognitive and brain ageing problems whilst discussing practical ideas for improving neurological disorders patients' quality of life.

Why to attend?

Conferences bring together all types of people affected by dementia-2024 those living with the condition, carers, academics, and those working with people with dementia. They’re an excellent opportunity to share knowledge, experiences and perspectives and gain deeper insights into the complex field of dementia, The conference will explore all areas of support and care for people with dementia and their carers in care homes, day care, acute hospitals, extra-care and sheltered housing, and the community. People living with dementia and their carers are closely involved as contributors throughout the event.

Sessions/Tracks

Track 1: Dementia

Dementia is that the term accustomed describe the symptoms of many conditions that touching the brain. The normally seen condition is Alzheimer’s, and alternative includes brain disease. Symptoms seen at early stages square measure temperament changes, withdrawal, state of mind, confusion and apathy. Early diagnosing helps with providing early treatment, support and designing. Medications would possibly facilitate with some symptoms of insanity, however no permanent cure, Majority of individuals with insanity square measure higher than age sixty-five, the condition isn't traditional for all older people. The prevalence of insanity gets high with age, however it’s not if an older person can develop it. whereas solely 1-in-4 people with Alzheimer’s sickness or insanity has been diagnosed. Few additional things we'd like to grasp regarding tube insanity, insanity with lewy bodies, Fronto-temporal insanity, Rarer causes of insanity, brain disorder, HIV-related psychological feature impairment, delicate psychological feature impairment.

Track 2: Dementia Lewy Body

After Alzheimer's disease it is the second most common type of progressive dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement. Lewy body dementia causes a progressive decline in mental abilities. People with Lewy body dementia may experience visual hallucinations and changes in alertness and attention. Different impacts incorporate Parkinson's illness like signs and side effects, for example, inflexible muscles, moderate development and tremors.

Track 3: Care Practice and Awareness

Persons with dementia have multiple psychological feature deficits that embody every memory impairment, that affects the flexibleness to seek out new data or recall data antecedently learned, and one or extra of the next symptoms-aphasia, apraxia, agnosia, or government dysfunction-such that the psychological feature deficits negatively have an impression on social or activity functioning with a giant decline in previous skills. to boot, persons with dementia generally suffer from comorbid conditions that extra complicate care and impede best outcomes. Therefore, developing caregiving ways individuals with dementia is pressing, given this increasing prevalence and so the associated burden that dementia places not solely on the people, but on the caregivers, relations, and so the resources of the health care system. standard views relating geriatric nursing generally paint a picture of the care as being slow paced sure and fewer hard than acute care. However, care of the aged, and significantly those with dementia, is sometimes difficult, unpredictable, and unstable, This session includes education and coaching of medical professionals, care and quality of life, Person focused care, psychological feature coaching, Support and coaching for casual and skilled careers, putt knowledge domain into apply, Non-pharmacological Interventions, practical foods, and art, music and life vogue.

Track 4: Ageing and Dementia

Half of people over age 50 have mild forgetfulness linked to age-associated memory impairment, although there are some normal age-related changes in memory and thinking, confusion and memory loss that interfere with your daily life are not part of the normal aging process. Other signs of ageing and dementia include, not being able to complete tasks independently, difficulty with naming items or close family members, forgetting the function of items, repeating questions, taking much longer to complete customary tasks, misplacing items frequently, not being able to retrace steps and getting lost.

Track 5: Dementia Nursing

Nursing of dementia patients need to understand them. Moreover, individuals with dementia regularly experience the evil impacts of comorbid conditions that additional befuddle psyche and square best outcomes. When things get challenging, nursing people with dementia, and their families: giving them one-to-one support, expert guidance and practical solutions. Dementia nursing is a specialized field within healthcare focused on the care of individuals with dementia, a condition characterized by the decline in cognitive functions such as memory, language, and problem-solving abilities. Nurses specializing in dementia care play a critical role in managing the complexities of the disease, providing both medical and emotional support to patients and their families.Dementia is not a single disease but a syndrome affecting cognitive functions, typically seen in elderly populations. Alzheimer's disease is the most common form, but other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. The progressive nature of dementia means that patients will eventually require comprehensive and continuous care as their condition worsens.

Track 6: Recent Studies & Case Reports

Dementia may be a progressive, irreversible decline in noesis that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementedness has many etiologies of that Alzheimer’s sickness (AD) is that the most typical.Drug development in AD is predicated on evolving pathophysiological theory. sickness modifying approaches embrace the targeting of amyloid process, aggregation of alphabetic character, endocrine signal, neuro-inflammation and neurochemical pathology, with efforts to date yielding abandoned hopes and current promise. reflective its dominance on the pathophysiological stage the amyloid cascade is central to several of the rising drug therapies.Recent studies and case reports play a crucial role in the advancement of medical knowledge and the enhancement of clinical practices. They provide insights into emerging trends, novel therapies, rare conditions, and the real-world application of theoretical knowledge. By examining recent studies and case reports, healthcare professionals can stay updated with the latest advancements and improve patient care. Recent studies in the medical field are often published in peer-reviewed journals and encompass a broad range of research areas. These studies can include randomized controlled trials, cohort studies, case-control studies, and longitudinal research. They contribute significantly to evidence-based medicine by providing robust data on the efficacy and safety of new treatments, diagnostic tools, and preventive measures. Recent studies also explore the underlying mechanisms of diseases, offering potential pathways for new therapeutic interventions.

Track 7: Alzheimer’s Disease

Alzheimer's disease is the most common cause of dementia among older adults that usually starts slowly and worsens over time. The most common early symptom is difficulty in remembering recent events short-term memory loss. By the final stage of Alzheimer’s, damage is widespread, and brain tissue gets shrunk significantly. As the disease advances, symptoms can include problems with language, mood swings, loss of motivation, not managing self-care, and behavioural issues. Gradually, bodily functions are lost, ultimately leading to death. Alzheimer’s disease is a progressive neurological disorder that leads to the degeneration and death of brain cells, resulting in memory loss, cognitive decline, and behavioral changes. It is the most common cause of dementia among older adults, accounting for 60-80% of dementia cases.The exact cause of Alzheimer's disease remains unclear, but it is characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain. These abnormal protein deposits disrupt neuron function and communication, leading to the death of brain cells. The disease typically begins in the hippocampus, a region crucial for memory formation, and gradually spreads to other parts of the brain. Diagnosing Alzheimer's disease involves a combination of medical history review, cognitive testing, neurological examinations, and imaging studies such as MRI or PET scans. Biomarkers, including cerebrospinal fluid analysis for amyloid-beta and tau proteins, are increasingly used to support diagnosis. Early detection is crucial for managing symptoms and planning for future care.

Track 8: Alzheimer’s Clinical Trials and Studies

Clinical trials square measure inquired regarding examinations junction rectifier in people to decide if medicines square measure protected and viable. While not clinical analysis and the help of human volunteers, there is no higher medications, no compensatory action and no cure for Alzheimer's ill.Clinical trials square measure often alluded to as clinical examinations; the terms square measure of utilized reciprocally, however their square measure retiring contrasts between them. Clinical trials look at new intercessions or medications to avoid, acknowledge or treat infection. A clinical report is any variety of clinical analysis together with people, paying very little heed as to if it's Associate in Nursing an intercession. Clinical examinations will likewise take a goose at totally different components of care, for instance, enhancing personal satisfaction.

Track 9: Novel Therapeutic Targets and Mechanisms for Treatment

Alzheimer's illness could be a progressive neurodegenerative disease that's characterized histopathologically by the presence of plaques, principally composed of Abeta amyloid and the tangles, principally composed of hyper phosphorylated alphabetic character. To date, there's no treatment which will reverse the illness, and everyone this medical specialty is directed to address the symptoms of the illness. Here we tend to describe the efforts dedicated to attack the plaques and, in additional detail, the method of neurofibrillary degeneration, connected to the presence of the hyper phosphorylated tubule associated super molecule alphabetic character. we've known the various purported targets for medical specialty and the current data on them.Treatment for Alzheimer's is coming into a brand new and exciting section, with many new medications starting clinical trials. several of those new therapies area unit supported our greatest current understanding of the pathologic process of Alzheimer's, and area unit designed to undertake to either slow or halt the progression of the illness. There are a unit many completely different theories underlying this effort, and these area unit in short reviewed. Therapies directed against some side of beta-amyloid formation, against neurofibrillary tangle formation and against the inflammatory response area unit all thought-about, as area unit the issues related to every space. it's nevertheless unclear that, if any of those approaches are undefeated, however the high level of activity in every of those 3 fields provides some hope that a good treatment for Alzheimer's is on the horizon.

Track 10: Amyloid Protein in Alzheimer’s and Dementia

The amyloid plaques and neurofibrillary tangles formation are thought to contribute to the degradation of the neurons (nerve cells) in the brain and the subsequent symptoms of Alzheimer's disease.Amyloid Plaques: One of the hallmarks of Alzheimer's disease is the accumulation of amyloid plaques between nerve cells (neurons) in brain. Amyloid generally indicates protein fragments that the body produces normally. Beta amyloid is a protein fragment from an amyloid precursor protein (APP). In a healthy brain, these protein fragments are broken down and get eliminated. In Alzheimer’s, the fragments get accumulated to form hard &insoluble plaques.Neurofibrillary Tangles: Neurofibrillary tangles are insoluble twisted fibers found inside the brain's cells, consisting primarily of a protein called tau, which forms structure called a microtubule. Transport of nutrients and other important substances from one part of the nerve cell to another done by help of microtubule. In Alzheimer's disease, the tau protein is abnormal and results in collapse of the microtubule structures.This session includes Amyloid Protein and Alzheimer’s Disease, Amyloid beta metabolism in Alzheimer’s, Brain accumulation of toxic amyloid beta, Amyloid Plaques and Neurofibrillary Tangles, Amyloid Neuroimaging and biomarkers, Amyloidosis and Neurodegeneration, The amyloid hypothesis and potential treatments, Amyloid beta deposition, cognition and brain volume.

Track 11: Molecular Genetics and Biology of Dementia

Alzheimer’s disease and Frontotemporal Dementia are two basic common types of neurodegenerative dementias. Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. This progress in genetic research is having a dramatic effect on our understanding of disease pathogenesis, by refining previous ideas and defining new primary disease mechanisms. The study of the molecular genetics and biology of dementia is pivotal in understanding the underlying mechanisms that drive the progression of various forms of dementia, including Alzheimer's disease, frontotemporal dementia, Lewy body dementia, and vascular dementia. This field of research delves into the genetic mutations, molecular pathways, and cellular processes that contribute to the onset and progression of these neurodegenerative disorders.Genetics plays a crucial role in the development of dementia. Several genes have been identified that significantly increase the risk of developing Alzheimer's disease, the most common form of dementia. For instance, The pathogenesis of dementia involves multiple molecular pathways. In Alzheimer's disease, the accumulation of beta-amyloid plaques and tau neurofibrillary tangles in the brain are hallmark features. Beta-amyloid peptides are produced from the cleavage of APP and aggregate to form plaques that disrupt cell function. Tau proteins, which normally stabilize microtubules, become hyperphosphorylated and form tangles inside neurons, leading to cell death. Similarly, in frontotemporal dementia, the accumulation of tau or TDP-43 protein aggregates disrupts cellular functions.

Track 12: Neurodegenerative Diseases

Neurodegenerative diseases incorporate wide selection of disorders, characterized by the progressive degeneration or death of nerve cells. It affects animal tissue and causes completely different psychological science manifestations furthermore. it's Associate in Nursing umbrella term for a variety of conditions that notably influence the neurons within the human brain. Genetic and environmental factors are shown to play an important role within the development of neurodegenerative diseases. Age is one in every of the key risk factors that's common between every type of neurodegenerative unwellness because it progresses at older ages ordinarily. Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system. These diseases primarily affect neurons, which are the building blocks of the nervous system, including the brain and spinal cord. The gradual loss of neuronal function leads to a decline in cognitive abilities, motor skills, and overall neurological health. Neurodegenerative diseases encompass a range of conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis.

Track 13: Psychiatry Mental Health Disorders

Psychiatric disorder is a mental illness which causes disturbs mood, thinking, and change behavior. It may depend on your family, your life experiences, such as stress or a history of abuse, Biological factors such as chemical imbalances in the brain, traumatic brain injury, use of alcohol or recreational drugs, having a serious medical condition like cancer. It can be diagnosed by physical exam and possibly lab tests, if your provider thinks that other medical conditions could be causing your symptoms. Treatment depends on which mental disorder you have and how serious it is. Psychiatry is a medical specialty focused on the diagnosis, treatment, and prevention of mental health disorders. These disorders encompass a wide range of conditions that affect mood, thinking, and behavior, including depression, anxiety disorders, schizophrenia, bipolar disorder, and substance use disorders. Psychiatrists are medical doctors who evaluate patients, provide therapy, prescribe medications, and work with other healthcare professionals to provide comprehensive care.Mental health disorders are complex conditions that can affect individuals' emotions, thoughts, and behaviors. They can arise from a combination of genetic, biological, environmental, and psychological factors. These disorders can significantly impair a person's ability to function in daily life and can lead to distress, disability, and reduced quality of life. Early diagnosis and effective treatment are crucial in managing symptoms and improving outcomes.

Track 14: Animal Models and Translational Medicine

Animal models for Alzheimer’s illness it's vital to trust the human makeup and what's being sculptural in terms of the animal makeup. The animal models of Alzheimer’s illness, supported the genetic science of the illness and the closely connected frontotemporal dementedness, replicate a minimum of a number of the pathology. Researchers are eminent at modeling terribly specific aspects of Alzheimer’s illness within the mouse (e.g., plaques, tangles). though these area unit incomplete models of the human illness, they need been well received within the field as doubtless relevant models to be used in drug discovery.Patients with Alzheimer’s illness can show each amyloidopathy and tauopathy; but scientists usually focus, in a very theory approach, on one or the opposite in Associate in nursing animal model. A participant value-added that although the anatomy within the mouse is totally different than the human, mutant letter of the alphabet mice area unit comparatively sensible models in this they recapitulate tau-dependent neurodegeneration. This has crystal rectifier several corporations to specialize in antibodies that block tau-dependent neurodegeneration in these mouse models.

Market Analysis

Dementia-2025 is general term for memory misfortune and alternative intellectual capacities sufficiently real to intervene existence. This gathering can build info, offer help, facilitate learning and alter families and carers to go looking out relevant administrations for his or her idolized one and to create up the foremost ideal home condition to assist healing from this fascinating and decimating malady, The global Alzheimer’s sickness (AD) market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of seventeen.5%, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics Alzheimer's disease is that the commonest style of dementia. According to United Nations agency 47.5 million folks have dementedness and each year 7.7 million new cases square measure showing. By 2030 total cases of dementia is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five.5 million. Alzheimer’s sickness contributes 60-70 you look after cases in dementia and second commonest condition of dementedness is tube-shaped structure dementia that contributes 2 hundredth of cases everywhere the globe. Total calculable price of dementedness is 818 billion U.S.A. $ in 2018, Alzheimer's disease and dementia represent a significant and growing public health challenge worldwide. Alzheimer's disease is the most common form of dementia, accounting for 60-80% of cases. It is characterized by progressive cognitive decline, memory loss, and behavioral changes. The increasing prevalence of these conditions, driven by an aging population, has profound implications for healthcare systems, caregivers, and society at large. This market analysis explores the current trends, demand drivers, challenges, and future prospects for Alzheimer's disease and dementia care. The global market for Alzheimer's disease and dementia is expanding rapidly due to the rising number of elderly individuals and the increasing awareness of these conditions. The market encompasses a range of products and services, including pharmaceuticals, diagnostics, and caregiving services. According to market reports, the global Alzheimer's disease market was valued at approximately USD 6.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of around 7% from 2021 to 2028.

Past Conference Report

We are thankful to all our wonderful Speakers, Conference Attendees, Students and Associations for making Dementia 2024 Conference the best ever!

18^th International Conference on Alzheimers Disease & Dementia was held on December 12-13, 2024 Rome, Italy; based on the theme “Explicating Advancements to Combat the Silent Epidemic of Dementia and Alzheimer". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pediatrics, who made this event an outstanding success.

Conference Series LLC Ltd expresses its gratitude to all the participants who made this event grad success.

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Dementia
Dementia Lewy Body
Neurology
Neurological Disorders
Care Practice and Awareness
Ageing and Dementia
Dementia Nursing
Recent Studies & Case Reports
Alzheimer’s Disease
Alzheimer’s Clinical Trials and Studies
Molecular Genetics and Biology of Dementia
Novel Therapeutic Targets and Mechanisms for Treatment
Neurodegenerative Diseases
Psychiatry Mental health disorders
Animal Models and Translational Medicine

Conference Series LLC Ltd offers its heart felt appreciation to keynote speakers, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interweaved with the organisation and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Dementia 2025, Conference Series LLC Ltd would like to announce the commencement of the “19^th International Conference on Alzheimers Disease & Dementia” to be held in July 07-08, 2025 Zurich, Switzerland. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Alzheimers Disease & Dementia.

Mark your calendars for the upcoming Conference; we are hoping to see you soon!

For More details visit: https://alzheimers-dementia.neuroconferences.com/

Let us meet again @ Dementia 2025

To Collaborate Scientific Professionals around the World

Conference Date July 07-08, 2025

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Dementia-2024 Conference

Supported By

Journals of Alzheimers Disease and Parkinsonism Journal of Neurological Disorders Journal of Neurology and Neuroscience

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Alzheimers Disease & Dementia

July 07-08, 2025 Zurich, Switzerland

Innovations in Alzheimers Disease Research and Treatment

Conference Series Conferences gaining more Readers and Visitors

Renowned Speakers

Jerzy Leszek

Suresh Kumar

Andres Barboza

Abdullatif Azab

Theodore A Petti

Theodore A Petti

Ahmed Ammar

Ad Verheul

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Dementia-2025

About Conference

Sessions/Tracks

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Keytopics